🔴 Goodrx is trading 8.4% down today in pre-market with no confirmed company-specific catalyst

Goodrx is trading 8.4% down at $3.26 after a sharp reversal from the September 14 close, with the decline appearing related to pre-market trading.

• No new company-specific announcement, earnings release, or analyst action dated September 15 was identified.
• The latest company news was the September 3 launch of GoodRx’s Companion Family Plan; recent earnings information remains older.
• No confirmed company-specific catalyst was identified.